Category: us corporate news

us corporate news

Nuburu, Inc. and Tekne S.p.A. Enter International Agreement to Deploy Graelion Vehicle in Ukraine – SEC 8-K Filing Summary

Minichart

March 6, 2026

Nuburu, Inc. Enters Material Definitive Agreement: Key Detai...

Continue Reading 0

us corporate news

Kite Realty Group Trust 8-K/A SEC Filing Details, XBRL Tags, and Company Information (March 2026)

Minichart

March 6, 2026

Kite Realty Group Trust Files Amendment to Correct Restricte...

Continue Reading 0

us corporate news

Liquidia Corporation 2025 Annual Report: Business Overview, Regulatory Updates, Pipeline, and Competitive Landscape

Minichart

March 6, 2026

Liquidia Corporation 2025 Annual Report: Key Investor Highli...

Continue Reading 0

us corporate news

CPI Card Group 2025 Annual Report: Business Overview, Strategy, Risks, and Financial Highlights

Minichart

March 6, 2026

CPI Card Group Inc. 2025 Annual Report – Key Insights for In...

Continue Reading 0

us corporate news

Tango Therapeutics 2025 10-K Annual Report: Business Overview, Risk Factors, and Financial Highlights

Minichart

March 6, 2026

Tango Therapeutics 2025 Annual Report: Key Investor Insights...

Continue Reading 0

us corporate news

Myers Industries, Inc. 2025 Annual Report: Business Overview, Financials, Risk Factors, and SEC Filings

Minichart

March 6, 2026

Myers Industries 2025 Annual Report - Key Investor Insights ...

Continue Reading 0

us corporate news

CLIMB BIO, INC. 2025 Annual Report: Business Overview, Risk Factors, Strategy, and Financials (Form 10-K)

Minichart

March 6, 2026

Climb Bio, Inc. 2025 Annual Report: Key Highlights & Shareho...

Continue Reading 0

us corporate news

Invivyd, Inc. 2023 Annual Report: Business Overview, Risk Factors, and Financial Statements (Form 10-K)

Minichart

March 6, 2026

Invivyd, Inc. Annual Report: Key Investor Insights Inv...

Continue Reading 0

us corporate news

Compass Therapeutics 2025 10-K: Clinical-Stage Oncology Pipeline, Risks, and Regulatory Overview

Minichart

March 6, 2026

Compass Therapeutics, Inc. 2025 Annual Report - Investor Hig...

Continue Reading 0

us corporate news

Kura Oncology, Inc. 2024 10-K Annual Report: Precision Cancer Medicines, Pipeline, and Financial Overview

Minichart

March 6, 2026

Kura Oncology 2025 Annual Report: Key Highlights and Investo...

Continue Reading 0